Groups recommend finasteride to lower prostate cancer risk

02/24/2009 | Washington Post, The · Google

The American Society of Clinical Oncology and the American Urological Association issued guidelines suggesting that the drug finasteride could reduce by as much as 25% the risk of prostate cancer in middle-age men who undergo regular screening. The drug, which is used to treat urinary problems and male pattern baldness, has been found to shrink the prostate and lower testosterone, which can contribute to cancer growth.

View Full Article in:

Washington Post, The · Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA